Status:
UNKNOWN
Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation
Lead Sponsor:
Hospital Italiano de Buenos Aires
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Auricular Fibrillation
Anticoagulant Drugs
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year
Detailed Description
The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year of use after their initiation during hospitalizat...
Eligibility Criteria
Inclusion
- Patient older than 18 years of age covered by our Health Care Insurance Plan.
- Indication for oral anticoagulation with an expected duration of use of no less than 1 year.
Exclusion
- Refusal to take part.
- Use of oral anticoagulants within 6 months prior to admission.
- Presence of mechanical prosthetic valve.
- Chronic renal failure with creatinine clearance \<30 mL/min (estimated using the MDRD formula).
Key Trial Info
Start Date :
April 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04133545
Start Date
April 4 2018
End Date
September 1 2020
Last Update
October 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina, C1199ABB